This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

So far this earnings season, companies in the S&P 500 that miss Wall Street's estimates for earnings per share and sales have ...

Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...

Historically, the stock has reacted positively to its earnings reports, with a one-day price increase in 67% of instances ...

Second-quarter earnings season is in full swing, and the results have been largely resilient so far. So why are stocks ...

Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.

Q2 2025 Management View Paul Richards, EVP and CFO, reported "For the second quarter, we reported a net income of $0.54 per ...

Earnings per share = $150,000,000 / 20,000,000 = $7.50 per share Sometimes companies attempt to manipulate their data to look better in order to attract more investments.

Earnings jumped to $1.03 a share, up from $0.60 a year ago, as Emerson ( NYSE: EMR) improved its pretax margin by 570 basis ...

In Q2, the chipmaker's data center revenue grew just 14% year over year, versus 57% in Q1, due to the export controls that ...